Genmab AS Vs. Target Industry Stock Comparison

Sell

25

GMAB
Genmab AS

Last Price:

20.48

Seasonality Move:

3.28%

Sell

25

TGT
Target

Last Price:

121.59

Seasonality Move:

4.08%

Sell

25

Genmab AS (GMAB) is a Sell

Is Genmab AS a Buy, Sell or Hold?

The current Genmab AS [GMAB] share price is $20.45. The Score for GMAB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

25

Target (TGT) is a Sell

Is Target a Buy, Sell or Hold?

The current Target [TGT] share price is $121.72. The Score for TGT is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
TGT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GMAB Stock Price Chart

What is Genmab AS's stock price today?

The Genmab AS share price today is $20.45
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing slight selling pressure.

TGT Stock Price Chart

What is Target's stock price today?

The Target share price today is $121.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGT is experiencing slight selling pressure.

GMAB Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.79	Sell
Relative Strength Index (14 RSI):	25.28	Sell
Chaikin Money Flow:	-57518	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	( - )	Buy
Bollinger Bands (100):	( - )	Buy

TGT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.84	Sell
Relative Strength Index (14 RSI):	23.97	Sell
Chaikin Money Flow:	-42314401	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	( - )	Buy
Bollinger Bands (100):	( - )	Buy

GMAB Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	21.34	Sell
20-day SMA:	22.22	Sell
50-day SMA:	23.4	Sell
200-day SMA:	26.95	Sell
8-day EMA:	21.16	Sell
20-day EMA:	22	Sell
50-day EMA:	23.31	Sell
200-day EMA:	26.81	Sell

TGT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	150.48	Sell
20-day SMA:	150.04	Sell
50-day SMA:	152.15	Sell
200-day SMA:	153.96	Sell
8-day EMA:	146.85	Sell
20-day EMA:	149.85	Sell
50-day EMA:	150.95	Sell
200-day EMA:	149.91	Sell

Genmab AS Earnings Growth & GMAB Earnings Dates

Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.28 per share.

Target Earnings Growth & TGT Earnings Dates

Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.33 per share, an increase this year of $2.81 per share, and an increase next year of $0.38 per share.

Genmab AS Technical Analysis

	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21
	Nov
	08	11	12	13	14	15	18	19	20	21
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Target Technical Analysis

	Nov 8	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21
	Nov
	08	11	12	13	14	15	18	19	20	21
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):